Since launching in 2011, Silicon Valley healthcare startup Sano Intelligence has kept a low profile. Despite raising $US20 million ($26 million) in venture capital, the company founded by ex-Bain Capital analyst and bioengineering grad Ashwin Pushpala has yet to release its product — a continuous glucose tracker that sticks to a users' skin and monitors blood through an app. Gizmodo has obtained new details about the device, and how the company intends to market it as a product for "metabolic insight" for non-diabetics, rather than to diabetics who regularly need to track their glucose. The strategy means Sano doesn't need FDA approval in the US, but doctors and diabetes experts interviewed by Gizmodo question whether the product would have any benefits to non-diabetics at all.
Tagged With diabetes
A Harvard research team led by biologist Douglas Melton has retracted a promising research paper following multiple failed attempts to reproduce the original findings.
Australian scientists have shown that brown fat — a special type of fat that burns energy to produce heat — may also help to keep blood sugar steady in adults. Researchers at Sydney’s Garvan Institute of Medical Research measured brown fat activity and blood glucose continuously in real time in study participants, and found that individuals with more brown fat had smaller fluctuations in blood sugar.
Their findings open new avenues for diabetes therapies that target brown fat.